Key genomic and clinicopathologic findings, such as the association of gene fusions with more aggressive disease, and the finding of recurrent DICER1 variants should help inform individualized treatment for patients and expand the understanding of the genetic mechanisms of thyroid tumors in children. Here, DICER1 is linked to thyroid tumor.